RxDoctor Payments Data

Adrienne Tinch

Family · Bowling Green, KYNPI 1487143418

Payments from drug & device makers

$5,468in general payments, 2019–2025

Across 350 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$2K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$436
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$425
  • Corium, LLC$324
  • Teva Pharmaceuticals USA, Inc.$179
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$5,468100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,468 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl33$46,119
AuvelityDextromethorphan Hbr/Bupropion23$22,942
OzempicSemaglutide13$11,802
Naltrexone Hcl47$1,555
Desvenlafaxine Succinate ErDesvenlafaxine Succinate31$1,028
Atomoxetine Hcl12$607
Albuterol Sulfate HfaAlbuterol Sulfate12$554
Quetiapine Fumarate34$385
Buspirone Hcl40$283
Nortriptyline Hcl11$250
Bupropion XlBupropion Hcl33$200
Duloxetine Hcl15$156
Montelukast Sodium22$152
Pantoprazole Sodium21$139
FenofibrateFenofibrate Nanocrystallized11$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,458$46,11933 claims
Axsome Therapeutics, Inc.Auvelity$1,599$22,94223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →